Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionSlateStone Wealth, LLC
Latest Disclosed Ownership39,196 shares
Latest Disclosed Value $ 4,024
SlateStone Wealth, LLC reports 0.81% decrease in ownership of ABL / Abbott Laboratories

On May 14, 2026 - SlateStone Wealth, LLC filed a 13F-HR form disclosing ownership of 39,196 shares of Abbott Laboratories (DE:ABL) valued at $3,481,389 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 39,518 shares of Abbott Laboratories. This represents a change in shares of -0.81% during the quarter. The current value of the position is $2,948,323 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F Abbott Laboratories COM 002824100 39,196 -322 -0.81 4 0.00 0.3317
2026-02-11 2025-12-31 13F Abbott Laboratories COM 002824100 39,518 -592 -1.48 5 -20.00 0.4143
2025-11-05 2025-09-30 13F Abbott Laboratories COM 002824100 40,110 -149 -0.37 5 0.00 0.4650
2025-08-12 2025-06-30 13F Abbott Laboratories COM 002824100 40,259 -425 -1.04 5 0.00 0.5120
2025-05-08 2025-03-31 13F Abbott Laboratories COM 002824100 40,684 -130 -0.32 5 25.00 0.5417
2025-02-10 2024-12-31 13F Abbott Laboratories COM 002824100 40,814 462 1.14 5 0.00 0.4529
2024-11-07 2024-09-30 13F Abbott Laboratories COM 002824100 40,352 -7,796 -16.19 5 -20.00 0.4143
2024-07-25 2024-06-30 13F Abbott Laboratories COM 002824100 48,148 405 0.85 5 0.00 0.5421
2024-04-26 2024-03-31 13F Abbott Laboratories COM 002824100 47,743 6,443 15.60 5 25.00 0.5450
2024-02-01 2023-12-31 13F Abbott Laboratories COM 002824100 41,300 -433 -1.04 5 0.00 0.5900
2023-10-12 2023-09-30 13F Abbott Laboratories COM 002824100 41,733 28,259 209.73 4 300.00 0.5879
2023-08-07 2023-06-30 13F Abbott Laboratories COM 002824100 13,474 -220 -1.61 1 0.00 0.2752
2023-08-08 2023-03-31 13F Abbott Laboratories COM 002824100 13,694 -451 -3.19 1 -99.94 0.2872
2023-02-01 2022-12-31 13F Abbott Laboratories COM 002824100 14,145 3,756 36.15 1,553 54.53 0.3747
2022-11-03 2022-09-30 13F Abbott Laboratories COM 002824100 10,389 -7,565 -42.14 1,005 -48.49 0.2674
2022-08-04 2022-06-30 13F Abbott Laboratories COM 002824100 17,954 -1,695 -8.63 1,951 -16.12 0.4984
2022-05-04 2022-03-31 13F Abbott Laboratories COM 002824100 19,649 -4,915 -20.01 2,326 -32.72 0.5187
2022-02-02 2021-12-31 13F Abbott Laboratories COM 002824100 24,564 14,156 136.01 3,457 181.06 0.7386
2021-10-28 2021-09-30 13F Abbott Laboratories COM 002824100 10,408 1,585 17.96 1,230 20.23 0.2816
2021-08-02 2021-06-30 13F Abbott Laboratories COM 002824100 8,823 4,305 95.29 1,023 89.09 0.2339
2021-04-19 2021-03-31 13F Abbott Laboratories COM 002824100 4,518 -16 -0.35 541 9.07 0.1337
2021-01-25 2020-12-31 13F Abbott Laboratories COM 002824100 4,534 -3,899 -46.24 496 -45.97 0.1237
2020-10-27 2020-09-30 13F Abbott Laboratories COM 002824100 8,433 -570 -6.33 918 11.54 0.1981
2020-07-29 2020-06-30 13F Abbott Laboratories COM 002824100 9,003 570 6.76 823 23.76 0.1840
2020-04-28 2020-03-31 13F Abbott Laboratories COM 002824100 8,433 -924 -9.87 665 -18.20 0.1892
2020-02-06 2019-12-31 13F Abbott Laboratories COM 002824100 9,357 1,332 16.60 813 21.16 0.1859
2019-11-05 2019-09-30 13F Abbott Laboratories COM 002824100 8,025 -1,900 -19.14 671 -19.64 0.1959
2019-08-05 2019-06-30 13F Abbott Laboratories COM 002824100 9,925 -90 -0.90 835 4.24 0.2351
2019-05-06 2019-03-31 13F Abbott Laboratories COM 002824100 10,015 740 7.98 801 19.37 0.2460
2019-02-13 2018-12-31 13F Abbott Laboratories COM 002824100 9,275 9,275 671 0.3086
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.